Home Newsfeeds US Authorities Engaged on Possible Credit Suisse-UBS Deal

US Authorities Engaged on Possible Credit Suisse-UBS Deal

-Bloomberg https://www.bloomberg.com/news/articles/2023-03-18/us-authorities-weighing-in-on-possible-credit-suisse-ubs-deal

byCharles Gross

March 18, 2023

1 minute read

-Bloomberg

https://www.bloomberg.com/news/articles/2023-03-18/us-authorities-weighing-in-on-possible-credit-suisse-ubs-deal

SAB Biotherapeutics Gets FDA Breakthrough Therapy Status On Influenza Treatment Candidate, Analysts Maintain Bullish Pitch

By Vandana Singh

April 18, 3:45 PM

Earlier today, SAB Biotherapeutics Inc’s (NASDAQ:SABS) SAB-176, an investigational therapy for post-exposure prophylaxis for influenza, received FDA Breakthrough Therapy Designation soon after…

SABS

Calix Issues Weak Q1 Forecast, Joins Diageo And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

By Avi Kapoor

January 30, 6:10 AM

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Tuesday.

BORR

Mizuho Initiates Coverage On Callon Petroleum with Buy Rating, Announces Price Target of $59

By Benzinga Newsdesk

January 10, 5:53 AM

Mizuho analyst Nitin Kumar initiates coverage on Callon Petroleum (NYSE:CPE) with a Buy rating and announces Price Target of $59.

CPE

Why Globalstar Shares Are Gaining Tuesday

By Adam Eckert

August 29, 9:50 AM

Globalstar Inc (NASDAQ: GSAT) shares are trading higher Tuesday after the company appointed Paul Jacobs to CEO and announced an

GSAT

US Authorities Engaged on Possible Credit Suisse-UBS Deal

Related Posts

SAB Biotherapeutics Gets FDA Breakthrough Therapy Status On Influenza Treatment Candidate, Analysts Maintain Bullish Pitch

Calix Issues Weak Q1 Forecast, Joins Diageo And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Mizuho Initiates Coverage On Callon Petroleum with Buy Rating, Announces Price Target of $59

Why Globalstar Shares Are Gaining Tuesday